Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2026
Rapid flow cytometric diagnosis of XIAP deficiency.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wakatsuki Ryosuke, Nishimura Madoka, Tomomasa Dan, Takahashi Shuhei, Suzuki Kyogo, Kawaguchi Koji, Saura Ryutaro, Inoue Shota, Takeuchi Ichiro, Arai Katsuhiro, Sugiyama Masanaka, Narishige Yuta, Oshima Akira, Tsumura Miyuki, Okada Satoshi, Hoshino Akihiro, Takagi Masatoshi, Kanegane Hirokazu
Аннотация
INTRODUCTION: X-linked inhibitor of apoptosis protein (XIAP) deficiency is an inborn error of immunity caused by pathogenic variants of XIAP. It presents diverse symptoms, including recurrent hemophagocytic lymphohistiocytosis and inflammatory bowel disease. Previous reports established a functional analysis method that quantitatively evaluates intracellular tumor necrosis factor-alpha (TNF-α) production capacity following muramyl dipeptide (MDP) stimulation using flow cytometry (MDP-flow TNF-α) for assessing XIAP deficiency. However, this method required 2 days to obtain results, which is a limitation.
METHOD: We established a method to measure the downregulation of L-selectin (CD62L) on the cell surface after MDP stimulation of monocytes and neutrophils from patients with XIAP deficiency using flow cytometry (MDP-flow CD62L) within 4 h. Moreover, we also evaluated MDP-flow CD62L in patients with XIAP deficiency after allogeneic hematopoietic cell transplantation (HCT) to evaluate its usefulness in functional analysis.
RESULTS: Six patients with XIAP variants, two with interleukin-1 receptor-associated kinase 4 deficiency, and healthy controls were analyzed. The mean percent inhibition of CD62L expression (%inhibition) was evaluated in monocytes and neutrophils. The mean inhibition rates of CD62L expression in monocytes and neutrophils from patients with XIAP deficiency were 5.96% and 6.20%, respectively, significantly lower than those from healthy controls (monocytes, 85.4%; neutrophils, 85.4%). Furthermore, in three patients with XIAP deficiency after HCT, the MDP-flow CD62L was evaluated post-HCT, confirming improvement in accordance with donor chimerism.
CONCLUSION: In XIAP deficiency, MDP-flow CD62L enabled faster functional analysis than MDP-flow TNF-α. These analyses are also useful for post-HCT functional assessment.
METHOD: We established a method to measure the downregulation of L-selectin (CD62L) on the cell surface after MDP stimulation of monocytes and neutrophils from patients with XIAP deficiency using flow cytometry (MDP-flow CD62L) within 4 h. Moreover, we also evaluated MDP-flow CD62L in patients with XIAP deficiency after allogeneic hematopoietic cell transplantation (HCT) to evaluate its usefulness in functional analysis.
RESULTS: Six patients with XIAP variants, two with interleukin-1 receptor-associated kinase 4 deficiency, and healthy controls were analyzed. The mean percent inhibition of CD62L expression (%inhibition) was evaluated in monocytes and neutrophils. The mean inhibition rates of CD62L expression in monocytes and neutrophils from patients with XIAP deficiency were 5.96% and 6.20%, respectively, significantly lower than those from healthy controls (monocytes, 85.4%; neutrophils, 85.4%). Furthermore, in three patients with XIAP deficiency after HCT, the MDP-flow CD62L was evaluated post-HCT, confirming improvement in accordance with donor chimerism.
CONCLUSION: In XIAP deficiency, MDP-flow CD62L enabled faster functional analysis than MDP-flow TNF-α. These analyses are also useful for post-HCT functional assessment.
Предметные рубрики MeSH
HumansFlow CytometryX-Linked Inhibitor of Apoptosis ProteinFemaleL-SelectinMaleChild, PreschoolMonocytesChildNeutrophilsInfantTumor Necrosis Factor-alphaAcetylmuramyl-Alanyl-IsoglutamineHematopoietic Stem Cell TransplantationGenetic Diseases, X-LinkedLymphohistiocytosis, HemophagocyticLymphoproliferative Disorders